Dipeptide inhibitors of angiogenesis

Martin Griffin (Inventor), Mileidys Perez (Inventor)

Research output: Patent


The present invention relates to inhibitors of tissue transglutaminase for use in the inhibition of angiogenesis in a subject. In particular, the invention provides compounds of Formula I for use in the treatment and/or prevention of angiogenic diseases and disorders of the eye, such as diabetic retinopathy and age-related macular degeneration (AMD). The invention further provides methods for inhibiting angiogenesis in a subject.
Original languageEnglish
Patent numberGB 1107576.9
Publication statusPublished - 6 May 2011


Dive into the research topics of 'Dipeptide inhibitors of angiogenesis'. Together they form a unique fingerprint.

Cite this